Search

Your search keyword '"Steingrover R"' showing total 41 results

Search Constraints

Start Over You searched for: Author "Steingrover R" Remove constraint Author: "Steingrover R"
41 results on '"Steingrover R"'

Search Results

1. Molecular characterization of MRSA collected during national surveillance between 2008 and 2019 in the Netherlands

2. A genetic cluster of MDR Enterobacter cloacae complex ST78 harbouring a plasmid containing bla VIM-1 and mcr-9 in the Netherlands

4. Plasmid diversity among genetically related Klebsiella pneumoniae bla KPC-2 and bla KPC-3 isolates collected in the Dutch national surveillance

5. Plasmid diversity among genetically related Klebsiella pneumoniae bla KPC-2 and bla KPC-3 isolates collected in the Dutch national surveillance

7. Transmission networks of HIV-1 among men having sex with men in the Netherlands

8. Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy : not all AIDS-defining conditions are created equal

9. Health-related quality of life and fatigue in HIV-1 infected patients diagnosed during primary versus chronic infection

10. No Treatment versus 24 or 60 Weeks of Antiretroviral Treatment during Primary HIV Infection: The Randomized Primo-SHM Trial

11. Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study

12. High prevalence of the metabolic syndrome in HIV-infected patients: impact of different definitions of the metabolic syndrome

13. Does short-term virologic failure translate to clinical events in antiretroviral-naïve patients initiating antiretroviral therapy in clinical practice?

14. Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction

15. Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration

16. Importance of baseline prognostic factors with increasing time since initiation of highly active antiretroviral therapy: collaborative analysis of cohorts of HIV-1-infected patients

17. Analysis of the effect of highly active antiretroviral therapy during acute HIV-1 infection on HIV-specific CD4 T cell functions

18. Temporary antiretroviral treatment during primary HIV-1 infection has a positive impact on health-related quality of life: data from the Primo-SHM cohort study

19. No treatment versus 24 or 60 weeks of antiretroviral treatment during primary HIV infection: The randomized primo-SHM trial

20. No Treatment versus 24 or 60 Weeks of Antiretroviral Treatment during Primary HIV Infection: The Randomized Primo-SHM Trial

21. Restoration of the CD4 T cell compartment after long-term highly active antiretroviral therapy without phenotypical signs of accelerated immunological aging

23. Restoration of the CD4 T cell compartment after long-term highly active antiretroviral therapy without phenotypical signs of accelerated immunological aging

27. Plasmid diversity among genetically related Klebsiella pneumoniae blaKPC-2 and blaKPC-3 isolates collected in the Dutch national surveillance.

28. Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America

29. Perinatal Outcomes in Vertically Infected Neonates During a Chikungunya Outbreak on the Island of Curaçao.

30. A lower viral set point but little immunological impact after early treatment during primary HIV infection.

31. No treatment versus 24 or 60 weeks of antiretroviral treatment during primary HIV infection: the randomized Primo-SHM trial.

32. Rising HIV-1 viral load set point at a population level coincides with a fading impact of host genetic factors on HIV-1 control.

33. Altered dynamics and differential infection profiles of lymphoid and myeloid cell subsets during acute and chronic HIV-1 infection.

34. High prevalence of reduced bone mineral density in primary HIV-1-infected men.

35. Transient lowering of the viral set point after temporary antiretroviral therapy of primary HIV type 1 infection.

36. HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy.

37. Restoration of the CD4 T cell compartment after long-term highly active antiretroviral therapy without phenotypical signs of accelerated immunological aging.

38. A sudden rise in viral load is infrequently associated with HIV-1 superinfection.

39. Viral dynamics after starting first-line HAART in HIV-1-infected children.

40. Analysis of the effect of highly active antiretroviral therapy during acute HIV-1 infection on HIV-specific CD4 T cell functions.

41. Outcome and predictors of failure of highly active antiretroviral therapy: one-year follow-up of a cohort of human immunodeficiency virus type 1-infected persons.

Catalog

Books, media, physical & digital resources